{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:14:29Z","timestamp":1791454469240,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Kantonsspital St.Gallen, Switzerland"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.clnesp.2020.09.020","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T22:24:31Z","timestamp":1602023071000},"page":"83-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Treatment efficacy of a low FODMAP diet compared to a low lactose diet in IBS patients: A randomized, cross-over designed study"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7949-0385","authenticated-orcid":false,"given":"Claudia","family":"Krieger-Gr\u00fcbel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senta","family":"Hutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Hiestand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"G\u00fcsewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Borovicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2020.09.020_bib1","first-page":"71","article-title":"The epidemiology of irritable bowel syndrome","volume":"6","author":"Canavan","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.clnesp.2020.09.020_bib2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2020.09.020_bib3","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.clinthera.2005.11.012","article-title":"The spectrum of irritable bowel syndrome: a clinical review","volume":"27","author":"Gilkin","year":"2005","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.clnesp.2020.09.020_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5056\/jnm17116","article-title":"Use of dietary management in irritable bowel syndrome: results of a survey of over 1500 U.S. Gastroenterologists","volume":"24","author":"Lenhart","year":"2018","journal-title":"J.\u00a0Neurogastroenterol. Motil."},{"key":"10.1016\/j.clnesp.2020.09.020_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ajg.2013.105","article-title":"Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life","volume":"108","author":"B\u00f6hn","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnesp.2020.09.020_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000051878","article-title":"Food-related gastrointestinal symptoms in the irritable bowel syndrome","volume":"63","author":"Simr\u00e9n","year":"2001","journal-title":"Digestion"},{"key":"10.1016\/j.clnesp.2020.09.020_bib7","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41395-018-0195-4","article-title":"A\u00a0systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPS diet in treating symptoms of irritable bowel syndrome","volume":"113","author":"Dionne","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnesp.2020.09.020_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.gastro.2013.09.046","article-title":"A\u00a0diet low in FODMAPs reduces symptoms of irritable bowel syndrome","volume":"146","author":"Halmos","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2020.09.020_bib9","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1365-2036.2010.04237.x","article-title":"Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon","volume":"31","author":"Barrett","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnesp.2020.09.020_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2013.386","article-title":"Differential effects of FODMAPs (Fermentable Oligo-, Di-, Mono-Saccharides and Polyols) on small and large intestinal contents in healthy subjects shown by MRI","volume":"109","author":"Murray","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnesp.2020.09.020_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu10111599","article-title":"Lactose maldigestion, malabsorption, and intolerance: a comprehensive review with a focus on current management and future perspectives","volume":"10","author":"Fassio","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2020.09.020_bib12","article-title":"Lactose intolerance but not lactose maldigestion is more frequent in patients with irritable bowel syndrome than in healthy controls: a meta-analysis","volume":"31","author":"Varju","year":"2019","journal-title":"Neurogastreonterol Motil"},{"key":"10.1016\/j.clnesp.2020.09.020_bib13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ajcn\/67.4.710","article-title":"Role of irritable bowel syndrome in subjective lactose intolerance","volume":"67","author":"Vesa","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2020.09.020_bib14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/00365520410005405","article-title":"Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study","volume":"39","author":"Farup","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clnesp.2020.09.020_bib15","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/nmo.12602","article-title":"Self-reported lactose intolerance in clinic patients with functional gastrointestinal symptoms: prevalence, risk factors, and impact on food choices","volume":"27","author":"Zheng","year":"2015","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.clnesp.2020.09.020_bib16","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/gutjnl-2017-313750","article-title":"The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS","volume":"66","author":"Staudacher","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.clnesp.2020.09.020_bib17","first-page":"712","article-title":"Updates to the Rome criteria for irritable bowel syndrome","volume":"10","author":"Chang","year":"2012","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2020.09.020_bib18","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2020.09.020_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/gut.2005.075127","article-title":"Use and abuse of hydrogen breath tests","volume":"55","author":"Simr\u00e9n","year":"2006","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.clnesp.2020.09.020_bib20","first-page":"1171","article-title":"Validation of the IBS-SSS","volume":"51","author":"Betz","year":"2013","journal-title":"Z\u00a0Gastroenterol"},{"issue":"9","key":"10.1016\/j.clnesp.2020.09.020_bib21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365529709011203","article-title":"Stool form scale as a useful guide to intestinal transit time","volume":"32","author":"Lewis","year":"1997","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"10.1016\/j.clnesp.2020.09.020_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015591","article-title":"Placebos without deception: a randomized controlled trial in irritable bowel syndrome","volume":"22","author":"Kaptchuk","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.clnesp.2020.09.020_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nut.2017.07.004","article-title":"Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: a systematic review and meta-analysis","volume":"45","author":"Schumann","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/j.clnesp.2020.09.020_bib24","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1053\/j.gastro.2017.06.010","article-title":"A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores Bifidobacterium species: a randomized controlled trial","volume":"153","author":"Staudacher","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2020.09.020_bib25","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/ajg.2016.434","article-title":"A randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D","volume":"111","author":"Eswaran","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.clnesp.2020.09.020_bib26","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/j.gastro.2015.07.054","article-title":"Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial","volume":"149","author":"Bohn","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2020.09.020_bib27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ncp.10233","article-title":"Low-FODMAP diet is associated with improved quality of life in IBS patients \u2013 a prospective observational study","volume":"34","author":"Kortlever","year":"2019","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnesp.2020.09.020_bib28","series-title":"Low lactose diet has a poor effect on function bowel symptoms in lactose intolerant patients SGG poster presentation","author":"Meyer","year":"2013"},{"key":"10.1016\/j.clnesp.2020.09.020_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00042737-200103000-00001","article-title":"Irritable bowel syndrome: is the search for lactose intolerance justified?","volume":"13","author":"Parker","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2020.09.020_bib30","first-page":"117","article-title":"Lactose malabsorption and irritable bowel syndrome. Effect of a log-term lactose-free diet","volume":"27","author":"Vernia","year":"1995","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.clnesp.2020.09.020_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.gastro.2018.03.063","article-title":"Improvement in gastrointestinal symptoms after cognitive behavior therapy for refractory irritable bowel syndrome","volume":"155","author":"Lackner","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2020.09.020_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.pain.2009.07.005","article-title":"Psychodynamic interpersonal therapy and improvement in interpersonal difficulties in people with severe irritable bowel syndrome","volume":"145","author":"Hyphantis","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.clnesp.2020.09.020_bib33","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(84)92793-4","article-title":"Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome","volume":"2","author":"Whorwell","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.clnesp.2020.09.020_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/gut.28.4.423","article-title":"Hypnotherapy in severe irritable bowel syndrome: further experience","volume":"28","author":"Whorwell","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.clnesp.2020.09.020_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10865-011-9391-z","article-title":"Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations","volume":"35","author":"Garland","year":"2012","journal-title":"J\u00a0Behav Med"},{"issue":"4","key":"10.1016\/j.clnesp.2020.09.020_bib36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1378\/chest.12-1055","article-title":"Daily diaries vs retrospective questionnaires to assess asthma control and therapeutic responses in asthma clinical trials: is participant burden worth the effort?","volume":"143","author":"Okupa","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.clnesp.2020.09.020_bib37","article-title":"Lactose intolerance but not lactose maldigestion is more frequent in patients with irritable bowel syndrome than in healthy controls: a meta-analysis","volume":"31","author":"Varj\u00fa","year":"2019","journal-title":"Neuro Gastroenterol Motil"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457720302072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457720302072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T23:34:13Z","timestamp":1717371253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457720302072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":37,"alternative-id":["S2405457720302072"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2020.09.020","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment efficacy of a low FODMAP diet compared to a low lactose diet in IBS patients: A randomized, cross-over designed study","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2020.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}